Tag Archives: S&P/ASX 100 S&P/ASX 200 S&P/ASX 300 ALL ORDINARIES S&P/ASX MIDCAP 50 S&P/ASX All Australian 200 S&P/ASX 200 Health Care

Healthscope Ltd Sale of standalone medical centres operations

Sale of standalone medical centres operations: Healthscope Ltd (ASX: HSO) has entered into an agreement to sell its standalone medical centres operations for A$55 million to Fullerton Primary Care Pty Ltd (subsidiary of Fullerton Australia). The transaction is expected to be complete by the end of September 2017. Healthscope’s standalone medical centres operations consist of 43 medical centres, four specialist

Read more

What is the latest with these 2 healthcare stocks – Healthscope and Primary Health Care

Sale of standalone medical centres operations: Healthscope Ltd (ASX: HSO) has entered into an agreement to sell its standalone medical centres operations for A$55 million to Fullerton Primary Care Pty Ltd (subsidiary of Fullerton Australia). The transaction is expected to be complete by the end of September 2017. Healthscope’s standalone medical centres operations consist of 43 medical centres, four specialist

Read more

Primary Healthcare – Profits at the lower end

Following a review of its unaudited results for FY 2017, Primary Health Care Limited (ASX:PRY) has confirmed guidance for FY 2017 at the lower end of its previous range at $92 million Underlying NPAT. A decline in Medical centers underlying EBIT performance is expected to be partially offset by a robust performance in Imaging, a modest increase in Pathology on

Read more

Time to sell Ansell

Recently, the group has executed a binding agreement for the sale of its Sexual Wellness (SW) business for US$600m to Humanwell Healthcare and CITIC Capital China Partners (Buyer Consortium), and the transaction is expected to get completed by the end of September 2017. Net after-tax cash proceeds to Ansell are expected to be approximately US$529m and the company also expects

Read more